BV
Biotechnology Value Fund L.P. disclosed a 8.4% stake in ALEC
Biotechnology Value Fund L.P. reported owning 8.4% of Alector, Inc. (ALEC) (9,374,267 shares) in a Schedule 13G filed Sep 18, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.